Albertini, M. R., Ranheim, E. A., Zuleger, C. L., Sondel, P. M., Hank, J. A., Bridges, A., . . . Galili, U. (2016). Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma. Cancer Immunol Immunother.
استشهاد بنمط شيكاغوAlbertini, Mark R., et al. "Phase I Study to Evaluate Toxicity and Feasibility of Intratumoral Injection of α-gal Glycolipids in Patients With Advanced Melanoma." Cancer Immunol Immunother 2016.
MLA استشهادAlbertini, Mark R., et al. "Phase I Study to Evaluate Toxicity and Feasibility of Intratumoral Injection of α-gal Glycolipids in Patients With Advanced Melanoma." Cancer Immunol Immunother 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.